Title

Tailored Bowel Preparation According to Bristol Stool Form Scale
Tailored Bowel Preparation According to Bristol Stool Form Scale: a Prospective, Randomized, Controlled, Investigator-blinded, Multicenter Study
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Status

    Completed No Results Posted
  • Study Participants

    700
The Bristol stool form scale ( BSFS) based tailored bowel cleansing regimen might be helpful to improve bowel cleansing quality before colonoscopy.
Colonoscopy is the standard approach for evaluating the colon currently. Thorough bowel cleansing is critical for adequate visualization of colonic mucosa during colonoscopy. Inadequate bowel cleansing results in adverse consequences for the examination, including lower adenoma detection rates, longer procedural time, lower cecal intubation rates, shorter intervals between examinations and an estimated 12-22% increase in overall colonoscopy cost.Unfortunately, despite advances in bowel preparation methods, up to one-third of all colonoscopies are reported to have an inadequate bowel preparation.

The Bristol stool form scale ( BSFS) was developed in 1988 by O'Donnell LJD et al and was widely applied in both gastrointestinal study and clinical practice. BSFS divides human stool into 7 different styles according to its moisture content. In our clinical work, we find that it is prone to gain poor bowel cleansing quality in patients who pass type 1or 2 stool. Unfortunately, there is lacking of study on tailored bowel preparation according to Bristol stool form scale. Thus, we intend to develop an easy, practical, BSFS based tailored bowel cleansing regimen, in order to serve clinical work and research.
Study Started
Jan 31
2015
Primary Completion
Oct 31
2015
Study Completion
Oct 31
2015
Last Update
May 02
2016
Estimate

Drug Standard Bowel Prep (2L PEG-ELP)

Subjects whose bristol stool forms are type 1 or 2, will be asked to take standard bowel prep (2L PEG-ELP) the same-day of procedure.

Drug 2L PEG-ELP and 10mg bisacodyl

Subjects whose bristol stool forms are type 1 or 2, will be asked to take standard bowel prep (2L PEG-ELP) the same-day of procedure and 10mg bisacodyl the day before procedure.

Drug Standard Bowel Prep (2L PEG-ELP)

Subjects whose bristol stool forms are type 3 to 7, will be asked to take standard bowel prep (2L PEG-ELP) the same-day of procedure.

group1 Experimental

Subjects whose bristol stool forms are type 1 or 2, will receive standard bowel prep (2L PEG-ELP) the same-day of procedure.

group2 Experimental

Subjects whose bristol stool forms are type 1 or 2, will be asked to take standard bowel prep (2L PEG-ELP) the same-day of procedure and 10mg bisacodyl the day before procedure. ( 2L PEG-ELP and 10mg bisacodyl )

group3 Active Comparator

Subjects whose bristol stool forms are type 3 to 7, will receive standard bowel prep (2L PEG-ELP) the same-day of procedure.

Criteria

Inclusion Criteria:

Patients 18 years of age or older,
scheduled to undergo elective outpatient colonoscopy,
and were able to provide informed consent.

Exclusion Criteria:

history of colorectal surgery
severe colonic stricture or obstructing tumour
dysphagia
compromised swallowing reflex or mental status
significant gastroparesis or gastric outlet obstruction
known or suspected bowel obstruction or perforation
severe chronic renal failure (creatinine clearance<30 ml/min
severe congestive heart failure (New York Heart Association class III or IV)
uncontrolled hypertension (systolic blood pressure>170 mm Hg, diastolic blood pressure>100 mm Hg)
inflammatory bowel disease or megacolon
dehydration
disturbance of electrolytes
pregnancy or lactation
haemodynamically unstable
unable to give informed consent.
No Results Posted